CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
28 hedge funds and large institutions have $107M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
16% more capital invested
Capital invested by funds: $92.8M → $107M (+$14.7M)
8% more funds holding
Funds holding: 26 → 28 (+2)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
+$15.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$13M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.34M |
| 4 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$940K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$812K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$4.74M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$2.4M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.07M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.42M |
| 5 |
RCM
Riverloft Capital Management
Miami Beach,
Florida
|
-$1.22M |
CYNA Hedge Fund Activity: Q3 2015 in Review
28 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q3 2015, worth a combined $107M — up 16% from $92.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CYNA positions and 7 closed out — a net gain of 2 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Aisling Capital, opening a new position worth an estimated $15.8M. The largest seller was Broadfin Capital, cutting an estimated $4.74M.
- 28 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q3 2015, up from 26 in Q2 2015.
- Funds reported $107M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q3 2015, up 16% quarter-over-quarter.
- 9 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q3 2015 and 7 closed out, a net change of +2 holders.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q3 2015 was Aisling Capital, an estimated $15.8M added.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q3 2015 was Broadfin Capital, an estimated $4.74M sold.
Based on aggregated 13F filings for Q3 2015.